New Zealand Bans Tobacco Sales for Future Generations

Dec.13.2022
New Zealand Bans Tobacco Sales for Future Generations
New Zealand introduces world's strictest anti-smoking law, banning tobacco sales to anyone born after 2009 and reducing nicotine content.

New Zealand has passed the world's strictest anti-smoking law which will prohibit future generations from purchasing tobacco. The new ban on smoking, approved by Parliament on Tuesday, sets an unprecedented standard in the fight against tobacco consumption.


This new law includes a ban on selling tobacco to anyone born on or after January 1st, 2009, with fines of up to 150,000 New Zealand dollars ($95,910 USD). The ban will last for the lifetime of the individual.


This legislation will also decrease the permissible nicotine content in tobacco products and reduce the number of retailers allowed to sell tobacco by 90%.


This legislation has expedited the process of achieving a smoke-free future," said Dr. Ayesha Verrall, Deputy Minister of Health, in a statement.


Thousands of people will live longer and healthier lives while the healthcare system will save $5 billion by not having to treat smoking-related illnesses, such as various types of cancer, heart disease, stroke, and amputation.


By the end of 2023, the number of retailers authorized to sell tobacco will decrease from 6,000 to 600.


New Zealand, one of the countries with the lowest adult smoking rates among the 38 nations in the Organization for Economic Cooperation and Development, is further tightening its anti-smoking laws as part of the government's goal to make the country "smoke-free" by 2025.


Bhutan, which banned cigarette sales in 2010, is set to enact stricter anti-smoking laws.


Over the past decade, the number of adult smokers in New Zealand has decreased by half, lowering to 8%, with 56,000 people quitting smoking last year. According to OECD data, 25% of French adults smoke in 2021.


Verrall stated that this legislation will help reduce the life expectancy gap between Māori and non-Māori citizens, which could be as high as 25% for women.


The ACT New Zealand, with 10 seats out of the total 120 in Parliament, has condemned the law, stating that it will result in the closure of small businesses and force people to resort to the black market.


No one wants to see people smoking, but the reality is that some people are willing to do so. The Labor nanny state ban will cause problems," said Deputy Leader Brooke van Velden.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Geneva Court Annuls Ban on Disposable E-Cigarette Sales, Says Power Lies With Federal Authorities
Geneva Court Annuls Ban on Disposable E-Cigarette Sales, Says Power Lies With Federal Authorities
The Geneva Court of Justice on Tuesday upheld appeals filed by four associations and companies active in the tobacco trade and annulled the Geneva legal provision banning the sale of disposable e-cigarettes, commonly known as “puffs.”
Apr.30 by 2FIRSTS.ai
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
U.S. International Trade Commission has refused to pause the import and sales bans imposed on cannabis vape company Stiiizy while it appeals the agency’s patent infringement ruling in its dispute with Pax Labs.
Apr.07 by 2FIRSTS.ai
PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
On April 22, 2026, Philip Morris International released its first-quarter 2026 results. The report showed net revenues of $10.146 billion, up 9.1% year on year; adjusted diluted EPS of $1.96, up 16.0%; and smoke-free products accounting for 43% of total net revenues. Based on first-quarter performance, the company raised its 2026 full-year adjusted diluted EPS forecast to $8.36 to $8.51, or $8.11 to $8.26 excluding currency.
Apr.23 by 2FIRSTS.ai
Russian Duma Speaker Says Amendment Giving Regions Power to Ban Vape Sales Is Planned for Adoption in May
Russian Duma Speaker Says Amendment Giving Regions Power to Ban Vape Sales Is Planned for Adoption in May
Russian State Duma Speaker Vyacheslav Volodin said an amendment that would give Russian regions the power to ban vape sales is planned for adoption in May. Volodin said the decision concerns the health of citizens, especially children. He also said doctors have recorded a 30% increase in patients with respiratory diseases caused or aggravated by vape use, with adolescents and people under 35 most often affected.
Apr.24 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai